IGC Pharma, Inc. (IGC)

[NetworkNewsWire]

IGC Announces Engagement of NetworkNewsWire

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its engagement of NetworkNewsWire (NNW) for corporate communications solutions. NNW is a multifaceted financial news and publishing company working to help public and private organizations find their voice and build market visibility by leveraging a rapidly expanding distribution network of more than 5,000 key syndication outlets. “We have an exciting pipeline of phytocannabinoid-based treatments based on our formulation for pain,” Ram Mukunda, CEO of IGC, stated in this morning’s news release. “As we move toward pre clinical and clinical trials, we are working with NetworkNewsWire to make sure the investment community is aware of the opportunities created by our progress — both from a corporate and broader medical standpoint.”

To view the full press release, visit http://nnw.fm/FDtY2

About IGC

India Globalization Capital is engaged in the development of cannabis-based therapies to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions. In support of this mission, IGC has assembled a portfolio of patent filings for its phytocannabinoid-based treatments. The company is based in Bethesda, Maryland. For more information visit www.igcinc.us